Conselium, an executive search firm, has completed a search on behalf of Alcon Labs, a division of Novartis. Mr. Duane Stumpf began his role of U.S. Compliance Monitoring Manager on Nov. 26, 2012 in their office in Fort Worth, Texas.
Mr. Stumpf’s Responsibilities include:
- Partner with U.S. Compliance Functions to understand compliance risks and agree on priorities to develop the U.S. compliance monitoring strategies
- Implement U.S. monitoring plans
- Utilize metrics and tools to monitor compliance; and, enforce standards to collect, consolidate and analyze information to identify trends and potential risk areas
- Perform monitoring activities for select business units
- Identify root causes and provide insight to the risk assessment and prioritization of mitigation activities
- Advise on appropriate remediation and ensure timely and appropriate corrective action is taken when compliance violations are identified
Mr. Stumpf was previously with Searchlight Compliance Advisors and Ernst & Young holding positions in compliance and forensic investigations.
Although it’s based in neutral Switzerland, Novartis has been aggressive in attacking illnesses on multiple fronts, including pharmaceuticals, vaccines, and consumer health. Its largest division, Pharmaceuticals, develops and manufactures prescription drugs for blood pressure, cancer, and other ailments. Novartis’ Sandoz subsidiary produces generic drugs and active pharmaceutical ingredients, while the Vaccine and Diagnostics segment makes immune health and blood-screening tools. Its Alcon division makes ophthalmic drugs, surgery systems, and contact lenses. The Consumer Health unit includes OTC medications such as Excedrin and Theraflu, as well as agricultural animal and pet care products.
Published by Conselium Executive Search, the global leader in compliance search.
